About US
Contact us
-
FDA grants orphan drug status for Senesco's SNS01-T in treatment of multiple myelomaSenesco Technologies, Inc. ("Senesco" or the "Company") (NYSE Amex: SNT), announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for the company's lead dr2011/1/4
-
SinoFresh, Green Valley Drug enter marketing relationship for Homeopathic Antiseptic Nasal SpraySinoFresh® HealthCare, Inc., (Pink Sheets:SFSH) is pleased to announce that its marketing division has secured an agency marketing relationship with Green Valley Drug, http://www.greenvalleymed.co2011/1/4
-
Akorn-Strides joint venture enters purchase agreement with Pfizer for ANDAsAkorn, Inc. (NASDAQ: AKRX), a niche generic pharmaceutical company, today reported that its Akorn-Strides LLC joint venture has entered into a purchase agreement with Pfizer Inc. to sell 16 Abbreviate2010/12/31
-
Cardiome Provides Update for Oral Vernakalant Development ProgramVANCOUVER, Dec. 29 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that it has been advised by its partner, Merck (known as MSD outside the United States and Canada), th2010/12/30
-
ISP to increase prices on 1,4 Butanediol (BDO) and derivatives sold in North America, including N-Methyl-2-Pyrrolidone (NMP), Gamma-Butyrolactone (BLO) and Tetrahydrofuran (THF).Wayne, NJ - December 8, 2010 – International Specialty Products Inc. (“ISP”) has announced a 5% price increase for 1,4 Butanediol (BDO) and derivatives sold in North America, including N-Methyl-2-Pyrr2010/12/30
-
ActivBiotics Pharma, LLC Terminates its Association with Triobiotics Pharma AGAtlanta– December 28, 2010 – ActivBiotics Pharma, LLC announced today that it has mutually agreed with former Triton Pharma AG to terminate their previously announced acquisition of ActivBiotics Pharm2010/12/29
-
American Regent Initiates Nationwide Voluntary Recall of Sodium Bicarbonate Injection, USP 7.5% and 8.4%, 50 mL Single Dose Vials Due to Particulate MatterSHIRLEY, N.Y., Dec. 23, 2010 /PRNewswire/ -- American Regent is conducting a nationwide voluntary recall to the consumer and user level of ALL unexpired lots of the following products: S o di u m B i2010/12/29
-
FDA Halts J&J Study Of Pain Drug Over SafetyWASHINGTON -- Johnson & Johnson said Tuesday that a study of its experimental pain drug, fulranumab, has been halted after the Food and Drug Administration put the trial on hold over concerns that2010/12/29
-
Teva Settles Takeda Patent LitigationIsrael-based pharmaceutical major Teva Pharmaceutical has reached a settlement with Takeda Pharmaceutical. Teva has entered into an agreement with Takeda over claims that the company breached pate2010/12/28
-
Sanofi-Aventis Acquires Ascendis Drug Delivery TechnologySanofi-Aventis has acquired Ascendis' proprietary TransCon Linker and Hydrogel carrier technology, allowing drug compounds to be released into the body in a precise, time-controlled fashion. The t2010/12/28